Evidence map›Paper›PMID 26662458›Full record

ArticleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2016

Lack of allergy to timothy grass pollen is not a passive phenomenon but associated with the allergen-specific modulation of immune reactivity.

D Hinz, G Seumois, A M Gholami, J A Greenbaum, J Lane, B White, D H Broide, V Schulten, J Sidney, P Bakhru and 7 more

Open access · greenAbstract read
In one paragraph

Article in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 38 citations in OpenAlex.

  1. The association of allergic sensitization patterns in early childhood with disease manifestations and immunological reactivity at 10 years of age.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2019
    Trial
  2. Trial
  3. Messenger RNA vaccines in the prevention of allergic diseases.The World Allergy Organization journal · 2025
    Review
  4. Chikungunya virus-specific CD4Cell reports. Medicine · 2025
    Article
  5. Article
  6. Review
  7. Cell reports methods · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

D HinzDivision of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
G SeumoisDivision of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
A M GholamiDivision of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
J A GreenbaumBioinformatics Core Facility, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
J LaneDivision of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
B WhiteDivision of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
D H BroideDepartment of Medicine, University of California San Diego, La Jolla, CA, USA.
V SchultenDivision of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
J SidneyDivision of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
P BakhruDivision of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
C OseroffDivision of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
E WambreBenaroya Research Institute at Virginia Mason, Seattle, WA, USA.
E A JamesBenaroya Research Institute at Virginia Mason, Seattle, WA, USA.
W W KwokBenaroya Research Institute at Virginia Mason, Seattle, WA, USA.
B PetersDivision of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
P VijayanandDivision of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
A SetteDivision of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
La Jolla Institute for Immunology · USVirginia Mason Medical Center · USUniversity of California, San Diego · US

Funding

Understanding mechanisms in specific immunotherapy (SIT)U19AI100275 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SETTE, ALESSANDRO · 2012 to 2017
$8.1M
Induction and signature of pathogenic T cells in allergyR01AI108839 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI WAMBRE, ERIK · 2014 to 2018
$2.1M
FACSAria II Cell SorterS10RR027366 · NCRR · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2011 to 2011
$514k
NIAID NIH HHS HHSN272200700048CNIAID NIH HHS R01 AI108839NIAID NIH HHS U19 AI100275
6 · The paper itself

Abstract

backgroundTimothy grass (TG) pollen is a common seasonal airborne allergen associated with symptoms ranging from mild rhinitis to severe asthma.

objectiveThe aim of this study was to characterize changes in TG-specific T cell responses as a function of seasonality.

methodsPeripheral blood mononuclear cells (PBMCs) obtained from allergic individuals and non-allergic controls, either during the pollen season or out of season, were stimulated with either TG extract or a pool of previously identified immunodominant antigenic regions.

resultsPBMCs from allergic subjects exhibit higher IL-5 and IL-10 responses in season than when collected out of season. In the case of non-allergic subjects, as expected we observed lower IL-5 responses and robust production of IFN-γ compared to allergic individuals. Strikingly, non-allergic donors exhibited an opposing pattern, with decreased immune reactivity in season. The broad down-regulation in non-allergic donors indicates that healthy individuals are not oblivious to allergen exposure, but rather react with an active modulation of responses following the antigenic stimulus provided during the pollen season. Transcriptomic analysis of allergen-specific T cells defined genes modulated in concomitance with the allergen exposure and inhibition of responses in non-allergic donors. CONCLUSION AND CLINICAL RELEVANCE: Magnitude and functionality of T helper cell responses differ substantially in season vs. out of season in allergic and non-allergic subjects. The results indicate the specific and opposing modulation of immune responses following the antigenic stimulation during the pollen season. This seasonal modulation reflects the enactment of specific molecular programmes associated with health and allergic disease.

Indexed as

ImmunomodulationPhenotypeAllergensCase-Control StudiesCytokinesFemaleGene Expression ProfilingGene Expression RegulationHLA AntigensHumansImmunologic MemoryLeukocytes, MononuclearLymphocyte ActivationLymphocyte CountMalePhleumAllergensCytokinesHLA AntigensRNA, Messengernon-allergicseasonalityT cell responsetimothy grass

Identifiers

PMID26662458
PMCPMC4846575
OpenAlexW2201693747

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.